-
1
-
-
84897532554
-
-
International Agency for Research on Cancer. Lung cancer estimated incidence, Mortality and Prevalence Worldwide in 2012, Access on: 2014-2-1
-
International Agency for Research on Cancer. Lung cancer estimated incidence, Mortality and Prevalence Worldwide in 2012. 2012. http:// globocan.iarc.fr/factsheet.asp. Access on: 2014-2-1.
-
(2012)
-
-
-
2
-
-
70049112736
-
Revisiting stage IIIB and IV non-small cell lung cancer: Analysis of the surveillance, epidemiology, and end results data
-
DOI: 10.1378/chest.08-2968
-
William WN Jr, Lin HY, Lee JJ, Lippman SM. Revisiting stage IIIB and IV non-small cell lung cancer: Analysis of the surveillance, epidemiology, and end results data. Chest. 2009;136:701-709.DOI: 10.1378/chest.08-2968.
-
(2009)
Chest
, vol.136
, pp. 701-709
-
-
William Jr., W.N.1
Lin, H.Y.2
Lee, J.J.3
Lippman, S.M.4
-
3
-
-
84862280868
-
RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/ carboplatin-treated advanced non-small cell lung cancer
-
DOI: 10.1007/s00280-012- 1834-x
-
Zhang GB, Chen J, Wang LR, Li J, Li MW, Xu N, et al. RRM1 and ERCC1 expression in peripheral blood versus tumor tissue in gemcitabine/ carboplatin-treated advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2012;69(5):1277-1287.DOI: 10.1007/s00280-012- 1834-x.
-
(2012)
Cancer Chemother Pharmacol
, vol.69
, Issue.5
, pp. 1277-1287
-
-
Zhang, G.B.1
Chen, J.2
Wang, L.R.3
Li, J.4
Li, M.W.5
Xu, N.6
-
4
-
-
77955635233
-
Cancer statistics, 2010
-
DOI: 10.3322/caac.20073
-
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300. DOI: 10.3322/caac.20073.
-
(2010)
CA Cancer J Clin
, vol.60
, Issue.5
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
5
-
-
34548724426
-
Genetic variation in the DNA repair genes is predictive of outcome in lung cancer
-
DOI: 10.1093/hmg/ddm190
-
Matakidou A, el Galta R, Webb EL. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. Hum Mol Genet. 2007;16:2333-2340.DOI: 10.1093/hmg/ddm190.
-
(2007)
Hum Mol Genet
, vol.16
, pp. 2333-2340
-
-
Matakidou, A.1
Galta, E.R.2
Webb, E.L.3
-
6
-
-
79957745242
-
Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
-
DOI: 10.1016/j.lungcan.2010.11.004
-
Liu L, Yuan P, Wu C, Zhang X, Wang F, Guo H, et al. Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. 2011; 73(1):110-115.DOI: 10.1016/j.lungcan.2010.11.004.
-
(2011)
Lung Cancer
, vol.73
, Issue.1
, pp. 110-115
-
-
Liu, L.1
Yuan, P.2
Wu, C.3
Zhang, X.4
Wang, F.5
Guo, H.6
-
7
-
-
84874527959
-
BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer
-
DOI: 10.1186/1471-2407-13-103
-
Yuanming L, Lineng Z, Baorong S, Junjie P, Sanjun C. BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer. BMC Cancer. 2013;13:103.DOI: 10.1186/1471-2407-13-103.
-
(2013)
BMC Cancer
, vol.13
, pp. 103
-
-
Yuanming, L.1
Lineng, Z.2
Baorong, S.3
Junjie, P.4
Sanjun, C.5
-
8
-
-
84888780166
-
Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy
-
DOI: 10.1183/09059180.00007113
-
Bergot E, Levallet G, Campbell K, Dubois F, Lechapt E, Zalcman G. Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy. Eur Respir Rev. 2013;22(130):565-576.DOI: 10.1183/09059180.00007113.
-
(2013)
Eur Respir Rev
, vol.22
, Issue.130
, pp. 565-576
-
-
Bergot, E.1
Levallet, G.2
Campbell, K.3
Dubois, F.4
Lechapt, E.5
Zalcman, G.6
-
9
-
-
58149177773
-
Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in nonsmall- cell lung cancer patients
-
DOI: 10.1371/ journal.pone.0003695
-
Boukovinas I, Papadaki C, Mendez P, Taron M, Mavroudis D, Koutsopoulos A, et al. Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in nonsmall- cell lung cancer patients. PLoS One. 2008;3(11):e3695.DOI: 10.1371/ journal.pone.0003695.
-
(2008)
PLoS One
, vol.3
, Issue.11
-
-
Boukovinas, I.1
Papadaki, C.2
Mendez, P.3
Taron, M.4
Mavroudis, D.5
Koutsopoulos, A.6
-
10
-
-
77957814960
-
Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy
-
Fujita H, Ohuchida K, Mizumoto K, Itaba S, Ito T, Nakata K, et al. Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy. Neoplasia. 2010;12(10):807-817.
-
(2010)
Neoplasia
, vol.12
, Issue.10
, pp. 807-817
-
-
Fujita, H.1
Ohuchida, K.2
Mizumoto, K.3
Itaba, S.4
Ito, T.5
Nakata, K.6
-
11
-
-
84878738921
-
Prognostic potential of ERCC1 protein expression & clinicopathologic factors in stage III/N2 non-small cell lung cancer
-
DOI: 10.1186/1749-8090-8-149
-
Yan D, Wei P, An G, Chen W. Prognostic potential of ERCC1 protein expression & clinicopathologic factors in stage III/N2 non-small cell lung cancer. J Cardiothorac Surg. 2013;8:149.DOI: 10.1186/1749-8090-8-149.
-
(2013)
J Cardiothorac Surg
, vol.8
, pp. 149
-
-
Yan, D.1
Wei, P.2
An, G.3
Chen, W.4
-
12
-
-
84869496414
-
Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy
-
DOI: 10.1016/j.ejca.2012.06.011
-
Sodja E, Knez L, Kern I, Ovčariček T, Sadikov A, Cufer T. Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy. Eur J Cancer. 2012; 48(18):3378-3385.DOI: 10.1016/j.ejca.2012.06.011.
-
(2012)
Eur J Cancer
, vol.48
, Issue.18
, pp. 3378-3385
-
-
Sodja, E.1
Knez, L.2
Kern, I.3
Ovčariček, T.4
Sadikov, A.5
Cufer, T.6
-
13
-
-
84880370948
-
MRNA Expression and Clinical Significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in Postoperative Patients with Non-Small Cell Lung Cancer
-
DOI: 10.7314/APJCP.2013.14.5.2987
-
Han Y, Wang XB, Xiao N, Liu ZD. mRNA Expression and Clinical Significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in Postoperative Patients with Non-Small Cell Lung Cancer. Asian Pac J Cancer Prev. 2013;14(5):2987-2990.DOI: 10.7314/APJCP.2013.14.5.2987.
-
(2013)
Asian Pac J Cancer Prev
, vol.14
, Issue.5
, pp. 2987-2990
-
-
Han, Y.1
Wang, X.B.2
Xiao, N.3
Liu, Z.D.4
-
14
-
-
0344237226
-
Tumor response to chemotherapy: The validity and reproducibility of RECIST guidelines in NSCLC patients
-
DOI: 10.1111/j.1349- 7006.2003.tb01394.x
-
Watanabe H, Yamamoto S, Kunitoh H, Sekine I, Yamamoto N, Ohe Y, Tamura T, Kodama T, Sugimura K, Saijo N. Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci. 2003;94(11):1015-20.DOI: 10.1111/j.1349- 7006.2003.tb01394.x
-
(2003)
Cancer Sci
, vol.94
, Issue.11
, pp. 1015-1020
-
-
Watanabe, H.1
Yamamoto, S.2
Kunitoh, H.3
Sekine, I.4
Yamamoto, N.5
Ohe, Y.6
Tamura, T.7
Kodama, T.8
Sugimura, K.9
Saijo, N.10
-
15
-
-
0022534749
-
Molecular characterization of the human excision repair gene ERCC-1: CDNA cloning and amino acid homology with the yeast DNA repair gene RAD10
-
DOI:10.1016/0092-8674(86)90014-0
-
van Duin M, de Wit J, Odijk H, Westerveld A, Yasui A, Koken MH, Hoeijmakers JH, Bootsma D. Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. Cell. 1986;44(6):913-923.DOI:10.1016/0092-8674(86)90014-0.
-
(1986)
Cell
, vol.44
, Issue.6
, pp. 913-923
-
-
van Duin, M.1
de Wit, J.2
Odijk, H.3
Westerveld, A.4
Yasui, A.5
Koken, M.H.6
Hoeijmakers, J.H.7
Bootsma, D.8
-
16
-
-
84885914044
-
ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: Results from a randomised, phase II trial
-
DOI: 10.1038/bjc.2013.576
-
Bauman JE, Austin MC, Schmidt R, Kurland BF, Vaezi A, Hayes DN, Mendez E, Parvathaneni U, Chai X, Sampath S, Martins RG. ERCC1 is a prognostic biomarker in locally advanced head and neck cancer: results from a randomised, phase II trial. Br J Cancer. 2013;109(8):2096-2105.DOI: 10.1038/bjc.2013.576.
-
(2013)
Br J Cancer
, vol.109
, Issue.8
, pp. 2096-2105
-
-
Bauman, J.E.1
Austin, M.C.2
Schmidt, R.3
Kurland, B.F.4
Vaezi, A.5
Hayes, D.N.6
Mendez, E.7
Parvathaneni, U.8
Chai, X.9
Sampath, S.10
Martins, R.G.11
-
17
-
-
84887156576
-
Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy
-
DOI: 10.1002/jso.23422
-
Huang MY, Tsai HL, Lin CH, Huang CW, Ma CJ, Huang CM, et al. Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy. J Surg Oncol. 2013;108(7):457-464.DOI: 10.1002/jso.23422.
-
(2013)
J Surg Oncol
, vol.108
, Issue.7
, pp. 457-464
-
-
Huang, M.Y.1
Tsai, H.L.2
Lin, C.H.3
Huang, C.W.4
Ma, C.J.5
Huang, C.M.6
-
18
-
-
84872737647
-
The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
-
DOI: 10.3892/ol.2012.1096
-
Liu YP, Ling Y, Qi QF, Zhang YP, Zhang CS, Zhu CT, Wang MH, Pan YD. The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. Oncol Lett. 2013;5(3):935-942.DOI: 10.3892/ol.2012.1096.
-
(2013)
Oncol Lett
, vol.5
, Issue.3
, pp. 935-942
-
-
Liu, Y.P.1
Ling, Y.2
Qi, Q.F.3
Zhang, Y.P.4
Zhang, C.S.5
Zhu, C.T.6
Wang, M.H.7
Pan, Y.D.8
-
19
-
-
84878386919
-
Clinicopathological significance of ERCC1 expression in breast cancer
-
DOI: 10.1016/j.prp.2013.02.009
-
Gerhard R, Carvalho A, Carneiro V, Bento RS, Uemura G, Gomes M, et al. Clinicopathological significance of ERCC1 expression in breast cancer. Pathol Res Pract. 2013;209(6):331-336.DOI: 10.1016/j.prp.2013.02.009.
-
(2013)
Pathol Res Pract
, vol.209
, Issue.6
, pp. 331-336
-
-
Gerhard, R.1
Carvalho, A.2
Carneiro, V.3
Bento, R.S.4
Uemura, G.5
Gomes, M.6
-
20
-
-
84874935746
-
Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: A system review and metaanalysis
-
DOI: 10.1186/1756-9966-32-15
-
Yang Y, Xie Y, Xian L. Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and metaanalysis. J Exp Clin Cancer Res. 2013;32:15.DOI: 10.1186/1756-9966-32-15.
-
(2013)
J Exp Clin Cancer Res
, vol.32
, pp. 15
-
-
Yang, Y.1
Xie, Y.2
Xian, L.3
-
21
-
-
75149189204
-
BRCA1 and its toolbox for the maintenance of genome integrity
-
DOI: 10.1038/nrm2831
-
Huen MS, Sy SM, Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol. 2010;11(2):138-148. DOI: 10.1038/nrm2831.
-
(2010)
Nat Rev Mol Cell Biol
, vol.11
, Issue.2
, pp. 138-148
-
-
Huen, M.S.1
Sy, S.M.2
Chen, J.3
|